UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Interior Resistance

Journal of interior design, 2021-03, Vol.46 (1), p.11-25

2021

Volltextzugriff (PDF)

Experience design and artefacts after the fact

CoDesign, 2006-06, Vol.2 (2), p.89-96

2006

Volltextzugriff (PDF)

Rethinking Inside the Box: Reflections on the Interiors Forum Scotland 2007 Conference

idea journal, 2007-07, Vol.8 (1), p.16-37

2007

Volltextzugriff (PDF)

NEXT GENERATION

Campaign, 2005-05, p.45

Milligan, Andy

2005

Volltextzugriff (PDF)

Dynamic species distribution models from categorical survey data

The Journal of animal ecology, 2013-11, Vol.82 (6), p.1215-1226

2013

Volltextzugriff (PDF)

A SARS-CoV-2 minimum data standard to support national serology reporting

Annals of clinical biochemistry, 2024-11, Vol.61 (6), p.418-445

2024

Volltextzugriff (PDF)

G protein–receptor kinases 5/6 are the key regulators of G protein–coupled receptor 35–arrestin interactions

The Journal of biological chemistry, 2023-10, Vol.299 (10), p.105218-105218, Article 105218

2023

Volltextzugriff (PDF)

Rituximab Plus Chlorambucil As First-Line Treatment for Chronic Lymphocytic Leukemia: Final Analysis of an Open-Label Phase II Study

Journal of clinical oncology, 2014-04, Vol.32 (12), p.1236-1241

2014

Volltextzugriff (PDF)

Eradication of minimal residual disease improves overall and progression‐free survival in patients with chronic lymphocytic leukaemia, evidence from NCRN CLL207: a phase II trial assessing alemtuzumab consolidation

British journal of haematology, 2017-02, Vol.176 (4), p.573-582

2017

Volltextzugriff (PDF)

Fludarabine, Cytarabine, Granulocyte Colony-Stimulating Factor, and Idarubicin With Gemtuzumab Ozogamicin Improves Event-Free Survival in Younger Patients With Newly Diagnosed AML and Overall Survival in Patients With NPM1 and FLT3 Mutations

Journal of clinical oncology, 2024-04, Vol.42 (10), p.1158-1168

2024

Volltextzugriff (PDF)

A randomized phase II trial of fludarabine, cyclophosphamide and mitoxantrone (FCM) with or without rituximab in previously treated chronic lymphocytic leukaemia

British journal of haematology, 2011-03, Vol.152 (5), p.570-578

2011

Volltextzugriff (PDF)

Eradication of minimal residual disease improves overall and progression‐free survival in patients with chronic lymphocytic leukaemia, evidence from NCRN CLL 207: a phase II trial assessing alemtuzumab consolidation

British journal of haematology, 2017-02, Vol.176 (4), p.573-582

2017

Volltextzugriff (PDF)

Results Of The Randomised Phase II NCRI Arctic (Attenuated dose Rituximab with ChemoTherapy In CLL) Trial Of Low Dose Rituximab In Previously Untreated CLL

Blood, 2013-11, Vol.122 (21), p.1639-1639

2013

Volltextzugriff (PDF)

Rituximab Plus Chlorambucil In Patients with CD20-Positive B-Cell Chronic Lymphocytic Leukemia (CLL): Final Response Analysis of An Open-Label Phase II Study

Blood, 2010-11, Vol.116 (21), p.697-697

2010

Volltextzugriff (PDF)

NCRN CLL207 Study of Alemtuzumab Consolidation In CLL: Final Response Assessment and Early Follow-up (on Behalf of the NCRI CLL Trials Sub-Group)

Blood, 2010-11, Vol.116 (21), p.60-60

2010

Volltextzugriff (PDF)

Stadiums, Race, and Water Infrastructure: Flooding on Atlanta's Southside

Sport Stadiums and Environmental Justice, 2023, p.91-104

1, 2023

Volltextzugriff (PDF)

An Open-Label Phase II Study to Investigate the Safety and Efficacy of Rituximab Plus Chlorambucil in Previously Untreated Patients with CD20-Positive B-Cell Chronic Lymphocytic Leukaemia (CLL)

Blood, 2009-11, Vol.114 (22), p.3428-3428

2009

Volltextzugriff (PDF)

NCRI CLL201 Trial: A Randomized Phase II Trial of Fludarabine, Cyclophosphamide and Mitoxantrone (FCM) with or without Rituximab in Previously Treated CLL

Blood, 2007-11, Vol.110 (11), p.752-752

2007

Volltextzugriff (PDF)

5.46 NCRN CLL207 Study of Alemtuzumab Consolidation in Chronic Lymphocytic Leukaemia: Response Assessment Follow-up and Pharmacokinetic studies (on Behalf of the NCRI CLL Trials Sub-Group)

Clinical lymphoma, myeloma and leukemia, 2011-10, Vol.11, p.S275-S276

2011

Volltextzugriff (PDF)

Reed Elsevier and the arms trade revisited

The Lancet (British edition), 2007-03, Vol.369 (9566), p.987-987

2007

Volltextzugriff (PDF)

Reed Elsevier and the arms trade revisited

The Lancet (British edition), 2007-03, Vol.369 (9566), p.987-987

2007

Volltextzugriff (PDF)

Perspectives in Plant Ecology, Evolution

Perspectives in plant ecology, evolution and systematics,

Volltextzugriff (PDF)

Book Reviews

Journal of Biological Education, 1997, Vol.31 (1), p.70-80

1997

Volltextzugriff (PDF)

Book Reviews

Journal of Biological Education, 1997, Vol.31 (1), p.70-80

1997

Volltextzugriff (PDF)

1 – 24 von 24

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieDirector

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(22)
Mit Volltextzugriff
(20)

Publikationsform

Sprache

Englisch
(24)

Erscheinungsjahr

n.n

Zeitschrift / Serie

Blood
(5)
British Journal Of Haematology
(3)
Journal Of Biological Education
(2)
Journal Of Clinical Oncology
(2)
The Lancet
(2)
Annals Of Clinical Biochemistry
(1)
Campaign
(1)
Clinical Lymphoma, Myeloma And Leukemia
(1)
Codesign
(1)
Idea
(1)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Interior Resistance

Experience design and artefacts after the fact

Rethinking Inside the Box: Reflections on the Interiors Forum Scotland 2007 Conference

NEXT GENERATION

Dynamic species distribution models from categorical survey data

A SARS-CoV-2 minimum data standard to support national serology reporting

G protein–receptor kinases 5/6 are the key regulators of G protein–coupled receptor 35–arrestin interactions

Rituximab Plus Chlorambucil As First-Line Treatment for Chronic Lymphocytic Leukemia: Final Analysis of an Open-Label Phase II Study

Eradication of minimal residual disease improves overall and progression‐free survival in patients with chronic lymphocytic leukaemia, evidence from NCRN CLL207: a phase II trial assessing alemtuzumab consolidation

Fludarabine, Cytarabine, Granulocyte Colony-Stimulating Factor, and Idarubicin With Gemtuzumab Ozogamicin Improves Event-Free Survival in Younger Patients With Newly Diagnosed AML and Overall Survival in Patients With NPM1 and FLT3 Mutations

A randomized phase II trial of fludarabine, cyclophosphamide and mitoxantrone (FCM) with or without rituximab in previously treated chronic lymphocytic leukaemia

Eradication of minimal residual disease improves overall and progression‐free survival in patients with chronic lymphocytic leukaemia, evidence from NCRN CLL 207: a phase II trial assessing alemtuzumab consolidation

Results Of The Randomised Phase II NCRI Arctic (Attenuated dose Rituximab with ChemoTherapy In CLL) Trial Of Low Dose Rituximab In Previously Untreated CLL

Rituximab Plus Chlorambucil In Patients with CD20-Positive B-Cell Chronic Lymphocytic Leukemia (CLL): Final Response Analysis of An Open-Label Phase II Study

NCRN CLL207 Study of Alemtuzumab Consolidation In CLL: Final Response Assessment and Early Follow-up (on Behalf of the NCRI CLL Trials Sub-Group)

Stadiums, Race, and Water Infrastructure: Flooding on Atlanta's Southside

An Open-Label Phase II Study to Investigate the Safety and Efficacy of Rituximab Plus Chlorambucil in Previously Untreated Patients with CD20-Positive B-Cell Chronic Lymphocytic Leukaemia (CLL)

NCRI CLL201 Trial: A Randomized Phase II Trial of Fludarabine, Cyclophosphamide and Mitoxantrone (FCM) with or without Rituximab in Previously Treated CLL

5.46 NCRN CLL207 Study of Alemtuzumab Consolidation in Chronic Lymphocytic Leukaemia: Response Assessment Follow-up and Pharmacokinetic studies (on Behalf of the NCRI CLL Trials Sub-Group)

Reed Elsevier and the arms trade revisited

Reed Elsevier and the arms trade revisited

Perspectives in Plant Ecology, Evolution

Book Reviews

Book Reviews

Aktive Filter

Suchergebnisse filtern